For readers following the the Biologic Patent Transparency Act, DrugPatentWatch has recently been cited in an article describing the act as “A Solution in Search of a Problem.” In his article,…
The post DrugPatentWatch in the news: The Biologic Patent …
DrugPatentWatch in the news: The Biologic Patent Transparency Act. Read Post »
This paper was originally published by Reed F. Beall, Jason W. Nickerson, Warren A. Kaplan, Amir Attaran in PLoS ONE 11(2): e0148939 under a Creative Commons Attribution License. Abstract Background…
The post Is Patent “Evergreening” Restricting Access…
Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products? Read Post »
Healthcare systems including hospitals are taking care-related and business-related steps to cope with rapidly increasing drug prices.
The post Rising Drug Prices: How Healthcare Systems Are Coping appeared first on DrugPatentWatch – Make Better Decisi…
Rising Drug Prices: How Healthcare Systems Are Coping Read Post »
ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators Kenneth L. Dorsney, Editor-in-Chief 985 pages (4 pounds!) Buy from Amazon A key component of the commercial and regulatory structure of…
The post ANDA Litigation: Strategies a…
ANDA Litigation: Strategies and Tactics for Pharmaceutical Patent Litigators Read Post »
Information contained in expired drug patents can be invaluable to researchers developing new products, but caution is required to avoid legal problems.
The post How Companies Can Extract Value from Expired Drug Patents appeared first on DrugPatentWatc…
How Companies Can Extract Value from Expired Drug Patents Read Post »
According to the Louisiana Department of Health, an estimated 500 people per year are infected with hepatitis C (HCV) in Louisiana. By 2016, the number of identified HCV cases in that state…
The post A ‘Netflix’ Model for Drug Pricing to Bring Treatmen…
A ‘Netflix’ Model for Drug Pricing to Bring Treatments to More People Read Post »
I will be in Philadelphia on April 11th and 12th and would enjoy the opportunity to meet with current and prospective clients to learn more about your needs. If you…
The post Meet in Philadephia/NJ appeared first on DrugPatentWatch – Make Better Decisi…
Successful drug patent challengers get 180 days of market protection The Food and Drug Administration rewards successful drug patent challengers by giving them 180 days of generic market exclusivity (see…
The post Day 181 Generic Drug Launch – A Fast a…
Day 181 Generic Drug Launch – A Fast and Cheap Way to Find Generic Entry Opportunities Read Post »
This article was originally published by Kiu Tay-Teo, PhD, André Ilbawi, MD, and Suzanne R. Hill, PhD in JAMA Netw Open. 2019;2(1):e186875. under the terms of the CC-BY License. Key Points Question How does income from…
The post Comparison of Sales In…
Generic Pharmaceutical Patent and FDA Law covers Food and Drug Administration approval of generic drugs and the interaction of patents and FDA law. Some books in this space are written…
The post Generic Pharmaceutical Patent and FDA Law appeared first …